EVNIN LUKE sold 4.0% of their position (128.19K shares) of WEREWOLF THERAPEUTICS, INC. on the open market
Open‑market sale worth $117.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/4/2025ACC: 0001134657-25-000014
Director10% Owner
Since Apr 2021
-128.19K
Net shares
Net seller
$117.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
128.19K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−38.04K
Price / share
$0.89
Trade value
$33.86K
% of position
1.2%
12/2/2025
3.20M→3.16M
Common Stock
Indirect
Shares
−36.73K
Price / share
$0.87
Trade value
$31.95K
% of position
1.2%
12/3/2025
3.16M→3.12M
Common Stock
Indirect
Shares
−53.42K
Price / share
$0.97
Trade value
$51.81K
% of position
1.7%
12/4/2025
3.12M→3.07M
Total
Net shares
−128.19K
Net value
-$117.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/2/2025 | S · Sale | −38.04K | $0.89 | $33.86K | 1.2% | 3.20M | 3.16M |
| Common Stock Indirect | 12/3/2025 | S · Sale | −36.73K | $0.87 | $31.95K | 1.2% | 3.16M | 3.12M |
| Common Stock Indirect | 12/4/2025 | S · Sale | −53.42K | $0.97 | $51.81K | 1.7% | 3.12M | 3.07M |
| Total | −128.19K | -$117.62K | ||||||
Derivative Transactions0
No derivative transactions reported